HL Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $489K | Sell |
1,190
-63
| -5% | -$25.9K | 0.01% | 513 |
|
|
2018
Q4 | $468K | Sell |
1,253
-169
| -12% | -$63.1K | 0.01% | 508 |
|
|
2018
Q3 | $575K | Buy |
1,422
+169
| +13% | +$68.3K | 0.01% | 496 |
|
|
2018
Q2 | $432K | Sell |
1,253
-20
| -2% | -$6.9K | 0.01% | 513 |
|
|
2018
Q1 | $438K | Sell |
1,273
-5
| -0.4% | -$1.72K | 0.01% | 517 |
|
|
2017
Q4 | $480K | Sell |
1,278
-85
| -6% | -$31.9K | 0.01% | 431 |
|
|
2017
Q3 | $609K | Hold |
1,363
| – | – | 0.01% | 447 |
|
|
2017
Q2 | $669K | Buy |
+1,363
| New | +$669K | 0.01% | 411 |
|
|
2017
Q1 | – | Sell |
-738
| Closed | -$271K | – | 689 |
|
|
2016
Q4 | $271K | Hold |
738
| – | – | 0.01% | 577 |
|
|
2016
Q3 | $297K | Hold |
738
| – | – | 0.01% | 538 |
|
|
2016
Q2 | $258K | Buy |
738
+50
| +7% | +$17.5K | 0.01% | 564 |
|
|
2016
Q1 | $248K | Buy |
688
+28
| +4% | +$10.1K | 0.01% | 565 |
|
|
2015
Q4 | $358K | Hold |
660
| – | – | 0.01% | 515 |
|
|
2015
Q3 | $307K | Buy |
660
+75
| +13% | +$34.9K | 0.01% | 521 |
|
|
2015
Q2 | $298K | Sell |
585
-45
| -7% | -$22.9K | 0.01% | 567 |
|
|
2015
Q1 | $284K | Buy |
630
+10
| +2% | +$4.51K | 0.01% | 580 |
|
|
2014
Q4 | $254K | Sell |
620
-350
| -36% | -$143K | 0.01% | 596 |
|
|
2014
Q3 | $350K | Buy |
+970
| New | +$350K | 0.01% | 501 |
|
|
2013
Q4 | – | Sell |
-675
| Closed | -$211K | – | 649 |
|
|
2013
Q3 | $211K | Buy |
+675
| New | +$211K | 0.01% | 542 |
|